PubMed:17980029 / 1631-1953 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/17980029","sourcedb":"PubMed","sourceid":"17980029","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/17980029","text":"The enhancement was associated with decreasing levels of tissue inhibitor of matrix metalloproteinase (TIMP)-2 and increasing levels of the urokinase-type plasminogen activator receptor (uPAR), Ets-1 (E26 transformation-specific-1), matrix metalloproteinase (MMP)-9 and RhoC (ras homolog gene family, member C) expression.","tracks":[{"project":"sentences","denotations":[{"id":"TextSentencer_T15","span":{"begin":0,"end":322},"obj":"Sentence"},{"id":"T15","span":{"begin":0,"end":322},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T15","pred":"source","obj":"sentences"},{"subj":"T15","pred":"source","obj":"sentences"}]},{"project":"UBERON-AE","denotations":[{"id":"PD-UBERON-AE-B_T8","span":{"begin":57,"end":63},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"attributes":[{"subj":"PD-UBERON-AE-B_T8","pred":"source","obj":"UBERON-AE"}]},{"project":"performance-test","denotations":[{"id":"PD-UBERON-AE-B_T1","span":{"begin":57,"end":63},"obj":"http://purl.obolibrary.org/obo/UBERON_0000479"}],"attributes":[{"subj":"PD-UBERON-AE-B_T1","pred":"source","obj":"performance-test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"sentences","color":"#93e5ec","default":true},{"id":"UBERON-AE","color":"#ecd993"},{"id":"performance-test","color":"#bf93ec"}]}]}}